Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers (2011)
- Authors:
- Autor USP: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1007/s00228-011-1003-x
- Subjects: FÁRMACOS (EFEITOS); ÓXIDO NÍTRICO; ESTRESSE OXIDATIVO; HIPERTENSÃO
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2011
- Source:
- Título: European Journal of Clinical Pharmacology
- ISSN: 0031-6970
- Volume/Número/Paginação/Ano: v. 67, n. 4, p. 365-370, 2011
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SILVA, Pâmela Souza et al. Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers. European Journal of Clinical Pharmacology, v. 67, n. 4, p. 365-370, 2011Tradução . . Disponível em: https://doi.org/10.1007/s00228-011-1003-x. Acesso em: 14 jan. 2026. -
APA
Silva, P. S., Fontana, V., Palei, A. C. T., Sertorio, J. T. C., Biagi, C., & Tanus-Santos, J. E. (2011). Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers. European Journal of Clinical Pharmacology, 67( 4), 365-370. doi:10.1007/s00228-011-1003-x -
NLM
Silva PS, Fontana V, Palei ACT, Sertorio JTC, Biagi C, Tanus-Santos JE. Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers [Internet]. European Journal of Clinical Pharmacology. 2011 ; 67( 4): 365-370.[citado 2026 jan. 14 ] Available from: https://doi.org/10.1007/s00228-011-1003-x -
Vancouver
Silva PS, Fontana V, Palei ACT, Sertorio JTC, Biagi C, Tanus-Santos JE. Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers [Internet]. European Journal of Clinical Pharmacology. 2011 ; 67( 4): 365-370.[citado 2026 jan. 14 ] Available from: https://doi.org/10.1007/s00228-011-1003-x - Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus
- Matrix metalloproteinase-9 genetic variation affect MMP-9 levels in obese children
- eNOS gene polymorphirms may modify the effects produced by cardiovascular drugs on myocardial eNOS expression and activity [Carta]
- Simvastatin treatment increases nitrite levels in obese women: Modulation by T−786C polymorphism of eNOS
- Antihypertensive effects of inducible nitric oxide synthase inhibition in experimental pre-eclampsia
- Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats
- Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes
- Chronic treatment with quercetin does not inhibit angiotensin-converting enzyme in vivo or in vitro
- Hemodynamic effects of inducible nitric oxide synthase inhibition combined with sildenafil during acute pulmonary embolism
- Interethnic differences in the distribution of clinically relevant vascular endothelial growth factor genetic polymorphisms
Informações sobre o DOI: 10.1007/s00228-011-1003-x (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
